Avisi Technologies
3 known investors
Avisi develops VisiPlate, a nanotechnology-enabled implant designed to lower intraocular pressure in patients with open-angle glaucoma. The company is conducting a pivotal clinical trial (SAPPHIRE) to evaluate the device as a minimally-invasive treatment option.
Deep TechHealthtechMedical Devices
Investors · 3
In the news
- Avisi Technologies Raises $11M to Advance Glaucoma Treatment - Penn Center for Innovationpci.upenn.edu · 2026
- Avisi raises $10.7M to advance study on VisiPlate glaucoma device - Avisi Technologies Inc.avisitech.com · 2026
- Avisi Technologies Raises $10.7 Million Series A to Advance Pivotal Glaucoma Device Trial - TipRanks.comtipranks.com · 2026
- Avisi Technologies Announces $10.7M Capital Raise to Advance Novel Glaucoma Device Developmentprnewswire.com · 2026
- Avisi Technologies Raises $10.7M in Series A Fundingfinsmes.com · 2026
- Avisi Technologies - 2025 Funding Rounds & List of Investors - Tracxntracxn.com · 2021